richard at baybridgebio.com
user: aaavl2821
3002 karma | created 8 years ago
recent submissions
Sophistical Refutations
(en.wikipedia.org)
1 pts|5 months ago|discuss
Sophist
(en.wikipedia.org)
15 pts|5 months ago|5 comments
Can AI predict clinical trial outcomes?
(baybridgebio.com)
2 pts|8 months ago|discuss
AI won't replace biotech analysts
(baybridgebio.com)
1 pts|8 months ago|discuss
Show HN: Research Pharma Markets with AI
(baybridgebio.com)
2 pts|11 months ago|discuss
Show HN: Search for drugs approved to treat a given disease
(baybridgebio.com)
1 pts|1 year ago|discuss
Better obesity drugs are coming soon
(baybridgebio.com)
2 pts|1 year ago|discuss
The Future of the Obesity Market
(baybridgebio.com)
1 pts|1 year ago|discuss
The obesity drug landscape in one chart
(baybridgebio.com)
3 pts|1 year ago|discuss
A primer on the obesity drug landscape
(baybridgebio.com)
2 pts|1 year ago|discuss
AI-enabled biotech startup analysis
(baybridgebio.com)
1 pts|2 years ago|discuss
Analyzing gene therapy startup in layman's terms
(baybridgebio.com)
1 pts|2 years ago|discuss
AI Analysis of Biotech Startups
(baybridgebio.com)
2 pts|2 years ago|discuss
AI investment analyst: initiating coverage on Neumora Therapeutics
(baybridgebio.com)
1 pts|2 years ago|discuss
Quantifying risk / reward in biotech investing
(baybridgebio.com)
1 pts|2 years ago|discuss
Valuing Biotech Licensing Deals
(baybridgebio.com)
1 pts|2 years ago|discuss
Show HN: Value Biotech Licensing Deals
(baybridgebio.com)
2 pts|2 years ago|discuss
Which VCs are still investing in biopharma?
(baybridgebio.com)
1 pts|2 years ago|discuss
Biotech VC on pace for worst year since 2016
(baybridgebio.com)
2 pts|2 years ago|discuss
The biotech venture capital crunch
(baybridgebio.com)
1 pts|2 years ago|discuss